Sundar Kodiyalam
Director/Board Member presso ALSP ORCHID ACQUISITION CORPORATION I
Profilo
Sundar Kodiyalam is the founder of Vatera Healthcare Partners.
He currently holds director positions at Global Alliance for TB Drug Development, Edgemont Pharmaceuticals LLC, Talaria Therapeutics, Inc., Oikos Holdings LLC, Ekteino Laboratories, Inc., Lodo Therapeutics Corp., EG 427, ALSP Orchid Acquisition Corp.
I, Amplipharm LLC, Forticell Bioscience, Inc., and Accelerator Services Corp.
He previously held director positions at Schering-Plough Corp., ASCIO Pharmaceuticals, Inc., Melinta Subsidiary Corp., Novartis Pharmaceuticals Corp., Pearl Therapeutics, Inc., and ImmusanT, Inc. He was also a Vice President at Forticell Bioscience, Inc. and a Senior Vice President at KOS Pharmaceuticals, Inc. He received a graduate degree from The Ohio State University and an undergraduate degree from the University of Madras.
Posizioni attive di Sundar Kodiyalam
| Società | Posizione | Inizio |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Director/Board Member | - |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | - |
EG 427
 EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | Director/Board Member | 27/03/2023 |
| Amplipharm LLC | Director/Board Member | - |
Talaria Therapeutics, Inc.
 Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The private company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley. | Director/Board Member | - |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Director/Board Member | 30/09/2021 |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Director/Board Member | - |
Ekteino Laboratories, Inc.
 Ekteino Laboratories, Inc. BiotechnologyHealth Technology Ekteino Laboratories, Inc. develops sustained-release drug delivery systems for chronic use medications. The private company is based in New York, NY. | Director/Board Member | - |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Director/Board Member | 01/01/2011 |
| ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Precedenti posizioni note di Sundar Kodiyalam
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Sundar Kodiyalam
| The Ohio State University | Graduate Degree |
| University of Madras | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
ASCIO Pharmaceuticals, Inc.
 ASCIO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ASCIO Pharmaceuticals, Inc. manufactures pharmaceutical products. It specializes in gastroenterology, oncology, and urology. The company is headquartered in Alpharetta, GA. | Health Technology |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Health Technology |
Talaria Therapeutics, Inc.
Talaria Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The private company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley. | Commercial Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Finance |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Vatera Healthcare Partners
 Vatera Healthcare Partners Investment ManagersFinance Vatera Healthcare Partners (Vatera Healthcare) is a venture capital subsidiary of Oikos Holdings LLC founded in 2007 by Michael Jaharis and Sundar Kodiyalam. The firm is headquartered in New York. | Finance |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Ekteino Laboratories, Inc. develops sustained-release drug delivery systems for chronic use medications. The private company is based in New York, NY. | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Health Technology |
EG 427
EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | Commercial Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |
| Amplipharm LLC |
- Borsa valori
- Insiders
- Sundar Kodiyalam
